about us
INNOV2GRO
Turning Breakthroughs into Market Leadership
ABOUT US
A senior operator's firm
Innov2Gro transforms breakthrough biopharma innovations into sustainable market leadership by providing hands-on strategic guidance, operational excellence, and full-accountability leadership. We partner with life science organizations across both innovation and commercialization, helping them navigate complex challenges, accelerate growth, optimize performance, and deliver meaningful impact for patients, partners, and global healthcare markets.
The model
Founder-led, built as a firm
Innov2Gro is founder-led and delivered through a curated network of senior operators, advisors, and domain specialists — matched to each mandate and held to a single operating standard. The model is built to scale, extending the same operator-level discernment across more engagements than any one leader could take on alone.
The difference
Operator-level discernment
Innov2Gro works at the commercial–technical interface — not only a commercial leaders who can sell, and not only a technical experts who can evaluate, but operators who work at both dimensions at once. That dual vantage is what makes the difference: it is how Innov2Gro judges whether a technology is truly differentiated, and whether the commercial opportunity behind it is real and buildable.
Mandates are taken selectively. Innov2Gro engages only with companies whose technology is genuinely best-in-class — or on a credible path to becoming best-in-class. Selection is based on operating-level evaluation, not pitch decks.
Founder
Founded and led by Behzad Mahdavi, Ph.D., MBA
Behzad founded Innov2Gro to bring senior operating leadership to biopharma companies where the technology is real but the commercial engine still needs to be built — and to deliver it at scale, through a network held to his own standard rather than as a single operator.
He is a senior commercial leader in biopharma services with deep operating experience across CDMO, CRO, and platform companies, built over two decades at global multinationals — Lonza, Catalent, and Ginkgo Bioworks — and at growth-stage companies through senior C-level and Executive Chairman roles.
His work spans technology and innovation management, commercial strategy, international expansion, strategic partnerships, M&A, and operational transformation — with particular strength in situations where the technology is real but the commercial machinery still needs to be built. Author of Mastering Commercial Innovation. Bilingual English/French, dual US/Canadian citizenship. PhD in Chemistry, MBA, Chemical Engineer. NACD Directorship Certified®.
Why Innov2Gro
Great science isn't enough
Innov2Gro is built on a simple conviction: in biopharma, strong science fails commercially far more often than it fails technically. The missing piece is rarely the technology — it’s an operator who can judge whether that technology is genuinely differentiated and then build the commercial engine to bring it to market. We take full accountability for that work, not a seat on the sidelines — and we put our name behind only the technology we’re convinced can lead its market. Because a breakthrough only matters once it reaches the market — and the patients who need it.